Search

Your search keyword '"Pais, Prem"' showing total 262 results

Search Constraints

Start Over You searched for: Author "Pais, Prem" Remove constraint Author: "Pais, Prem" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
262 results on '"Pais, Prem"'

Search Results

3. Tobacco use and risk of acute stroke in 32 countries in the INTERSTROKE study: a case–control study

5. Secondary prevention with a structured semi-interactive stroke prevention package in INDIA (SPRINT INDIA): a multicentre, randomised controlled trial

7. External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry

8. Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial

9. Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis

11. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

12. Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis

13. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

14. Resource and Infrastructure-Appropriate Management of ST-Segment Elevation Myocardial Infarction in Low- and Middle-Income Countries

15. Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study

16. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study

17. Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics

19. Tackling NCD in LMIC: Achievements and Lessons Learned From the NHLBI–UnitedHealth Global Health Centers of Excellence Program

20. Characteristics, clinical practice patterns, and outcomes of strokes in India: INSPIRE—A multicentre prospective study.

23. Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide

24. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

26. The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial: Results of the Continuous Electrocardiographic Assessment Substudy

27. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

28. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

29. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

31. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study

34. Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial.

36. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study

38. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

39. Aspirin and extended-release Dipyridamole versus Clopidogrel for recurrent stroke

40. Telmisartan to prevent recurrent stroke and cardiovascular events

41. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction

43. Dabigatran Versus Warfarin: Effects on Ischemic and Hemorrhagic Strokes and Bleeding in Asians and Non-Asians With Atrial Fibrillation

46. Apixaban versus Warfarin in Patients with Atrial Fibrillation

47. Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

48. Apixaban in Patients with Atrial Fibrillation

50. Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease.

Catalog

Books, media, physical & digital resources